May 12, 2017 / 8:14 AM / 3 months ago

BRIEF- Ono Pharmaceutical signs co-development and marketing collaboration agreement with Seikagaku

May 12(Reuters) - Ono Pharmaceutical Co Ltd

* Says Seikagaku Corp and Ono Pharmaceutical Co., Ltd. have reached a basic agreement related toco-development and marketing collaboration on SI-613 under development by Seikagaku for the treatment of osteoarthritis in Japan

Source text in Japanese:goo.gl/lKEvJd

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below